Inflammation News and Research

RSS

Cyclists who drink tart cherry juice experience less inflammation and oxidative stress

Cyclists who drank Montmorency tart cherry juice concentrate before a three-day simulated race experienced less inflammation and oxidative stress compared to those who drank another beverage, according to a recent U.K. study published in the journal Nutrients.

3 Jun 2014

Study uncovers marijuana's potential to treat autoimmune diseases

A team of University of South Carolina researchers led by Mitzi Nagarkatti, Prakash Nagarkatti and Xiaoming Yang have discovered a novel pathway through which marijuana can suppress the body's immune functions. Their research has been published online in the Journal of Biological Chemistry.

3 Jun 2014

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

We already understand the many steps involved in blood clotting in great mechanistic detail. The process of blood vessels closing off in response to injury is necessary for preserving life, but blood platelets that are over-active, or activated inappropriately because of unstable plaque, can lead to heart attacks and strokes.

3 Jun 2014

Endo International subsidiary sells pharmaceutical drug discovery platform to AsanaBioSciences

Endo International plc today announced that its Endo Pharmaceuticals subsidiary has completed the sale of its branded pharmaceutical drug discovery platform to AsanaBioSciences, LLC, an independent member of the Amneal Alliance of Companies.

2 Jun 2014

Study suggests new targets for treating rare genetic disorder and cancer

The combined action of two enzymes, Srs2 and Exo1, prevents and repairs common genetic mutations in growing yeast cells, according to a new study led by scientists at NYU Langone Medical Center.

2 Jun 2014

Findings could lead to treatments for blood disorders associated with iron deficiencies and overloads

A UCLA research team has discovered a new hormone called erythroferrone, which regulates the iron supply needed for red blood-cell production.

2 Jun 2014

New software tool helps identify genetic mutations linked to increased risk for cancer

Researchers at The University of Texas MD Anderson Cancer Center and other institutions have applied a newly developed software tool to identify genetic mutations that contribute to a person's increased risk for developing common, complex diseases, such as cancer.

31 May 2014

CIRM grants $5.6 million to develop HIV/AIDS therapeutic using Sangamo's ZFN genome-editing technology

Sangamo BioSciences, Inc. announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million Strategic Partnership Award to fund clinical studies at City of Hope to develop a potentially curative ZFP Therapeutic for HIV/AIDS based on the application of Sangamo's zinc finger nuclease (ZFN) genome-editing technology in hematopoietic stem/progenitor cells (HSPCs).

31 May 2014

Researchers develop virtual platform that measures level of addiction of smokers

In Mexico, 21.7 percent of the population smokes, which is associated with 95 percent of  lung cancer cases and the development of 29 more different conditions.

31 May 2014

Physicians and scientists to discuss health, fitness and well-being at ACSM Annual Meeting

The 61st ACSM Annual Meeting brings more than 6,000 physicians, scientists, educators, students and others to the Orange County Convention Center in Orlando, May 27-31.

30 May 2014

Blood gene expression profile identifies patients with elevated risk of cardiovascular death

A study of 338 patients with coronary artery disease has identified a gene expression profile associated with an elevated risk of cardiovascular death. Used with other indicators such as biochemical markers and family history, the profile - based on a simple blood test - may help identify patients who could benefit from personalized treatment and counseling designed to address risk factors.

30 May 2014

Reduced glomerular filtration rate is independent risk factor for renal and urothelial cancer

Researchers who investigated the level of kidney function and subsequent cancer risk in more than one million adults have found that reduced glomerular filtration rate (GFR) — a key measure of reduced kidney function and chronic kidney disease (CKD) — is an independent risk factor for renal and urothelial cancer but not other cancer types.

30 May 2014

Women with PCOS more likely to experience chronic low-grade inflammation during pregnancy

Women who have polycystic ovary syndrome - the most common hormone disorder in women of reproductive age - are more likely to experience chronic low-grade inflammation during pregnancy than counterparts who do not have the condition, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

30 May 2014

Critically ill patients receiving steroids in ICU are more likely to develop delirium

New Johns Hopkins research suggests that critically ill patients receiving steroids in a hospital’s intensive care unit (ICU) are significantly more likely to develop delirium. Results of their research, they say, suggest minimizing the use of steroids could reduce delirium in the ICU.

28 May 2014

Stem cells in outer blood vessel wall appear to involve in brain reaction following stroke

Two years ago, a new type of stem cell was discovered in the brain that has the capacity to form new cells.

28 May 2014

Study suggests proton therapy may be effective, less toxic treatment option for head and neck cancer

In a small study, researchers from The University of Texas MD Anderson Cancer Center found that 93 percent of head and neck cancer patients treated with multi-field optimization intensity modulated proton therapy (MFO-IMPT) were cancer-free 28 months after treatment.

28 May 2014

Patients receiving steroids in hospital's ICU more likely to develop delirium, says study

New Johns Hopkins research suggests that critically ill patients receiving steroids in a hospital's intensive care unit (ICU) are significantly more likely to develop delirium. Results of their research, they say, suggest minimizing the use of steroids could reduce delirium in the ICU.

28 May 2014

Inflammation News and Research

Cyclists who drink tart cherry juice experience less inflammation and oxidative stress

Study uncovers marijuana's potential to treat autoimmune diseases

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

Endo International subsidiary sells pharmaceutical drug discovery platform to AsanaBioSciences

Study suggests new targets for treating rare genetic disorder and cancer

Findings could lead to treatments for blood disorders associated with iron deficiencies and overloads

New software tool helps identify genetic mutations linked to increased risk for cancer

CIRM grants $5.6 million to develop HIV/AIDS therapeutic using Sangamo's ZFN genome-editing technology

Researchers develop virtual platform that measures level of addiction of smokers

Physicians and scientists to discuss health, fitness and well-being at ACSM Annual Meeting

Blood gene expression profile identifies patients with elevated risk of cardiovascular death

Reduced glomerular filtration rate is independent risk factor for renal and urothelial cancer

Women with PCOS more likely to experience chronic low-grade inflammation during pregnancy

Critically ill patients receiving steroids in ICU are more likely to develop delirium

Stem cells in outer blood vessel wall appear to involve in brain reaction following stroke

Study suggests proton therapy may be effective, less toxic treatment option for head and neck cancer

Patients receiving steroids in hospital's ICU more likely to develop delirium, says study

Researchers develop active agents that may improve healing of inflammatory illnesses

Peptide antibodies hit immune-response-stifling MDSCs without harming other vital cells

Experts discuss potential advantages of bioresorbable vascular scaffolds at EuroPCR 2014

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News